← Back to searchRecruitingRecruiting
Focal Therapy for Localized Prostate Cancer
NCT06270043 · University of California, San Diego
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
A Prospective Registry and Longitudinal Study of Patients Undergoing Focal Therapy for Localized Prostate Cancer
About this study
This observational study will serve to collect data from medical record and review questionnaires before and after focal ablation of prostate tissue. All enrolled subjects will have already undergone or scheduled to receive the focal therapy as part of their prostate cancer treatment.
Eligibility criteria
Inclusion Criteria:
* Subject has elected or already undergone focal therapy as their standard of care treatment method and declined alternative treatment (active surveillance, radical prostatectomy, and radiation therapy)
* PSA ≤ 20
* Ability to complete informed consent form
Exclusion Criteria:
* Contraindication to follow-up multi parametric MRI or prostate biopsy
* Unable to tolerate general or regional anesthesia
Study design
Enrollment target: 500 participants
Age groups: adult, older_adult
Timeline
Starts: 2024-02-01
Estimated completion: 2034-02-01
Last updated: 2024-02-26
Interventions
Procedure: Focal Therapy
Primary outcomes
- • Oncological Response (1 year)
Sponsor
University of California, San Diego · other
Contacts & investigators
ContactJuan Javier-DesLoges, MD · contact · jjavierdesloges@health.ucsd.edu · 858-657-8786
All locations (1)
University of California, San DiegoRecruiting
La Jolla, California, United States